NeoImmune ^Company

Developer of industry leading reagents designed for minimal residual disease (MRD) testing. The company specializes in key technologies for high throughput reading and writing of T and B lymphocyte receptor repertoire, committing to improving disease detection through immune system study.NeoImmune Company Profile: Valuation, Funding & Investors - Pit…pitchbook.com/profiles/company/484421-32?